Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection29

Select a period of time:

Views

Views
January 20250
February 20252
March 20254
April 20252
May 20250
June 20250
July 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore4
United States2
Brazil1
Chile1
Germany1
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1
Santiago1
São Paulo1